Divis Laboratories

BSE : 532488 | NSE : DIVISLAB

Industry : Pharma Drugs | ISIN : INE361B01024 | FreeFloat : 51.21% | FnO : Yes | LotSize : 150


Intellectual Capital (IC)32,852.69
Net Worth (NW)12,134.68
Intrinsic Worth (IW)44,987.37
Market Cap (MC)98,361.41
Economic Value Added77.40
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)73.03%
IC Gross Margin (EBITDA/IC)12.73%
IC Net Margin (NPT/IC)9.44%
Knowledge Turnover (Sales/IC)0.29
Market to Intrinsic Value (MC/IW)2.19

As OfIntrinsic ValueMarket Price
30 Sep 2022Rs. 1,694.64Rs. 3,705.20
30 Jan 2023 ---- Rs. 3,366.40
-21.05     -0.63%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 3,362.55ReduceBuy on Dips
KB > 50% : Yes50 DMA : Rs. 3,380.19
0 < M2IV < 1 : NoVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-19
C
1396.26
1437.93
493.90
447.20
487.32
359.09
359.09
Mar-20
C
1389.71
1466.44
444.45
394.67
470.96
388.23
388.23
Jun-20
C
1730.47
1747.80
700.08
643.88
660.98
492.06
492.06
Sep-20
C
1749.30
1762.94
754.78
693.65
693.49
519.59
521.35
Dec-20
C
1701.44
1720.76
710.53
642.35
642.08
470.62
471.20
Mar-21
C
1788.19
1811.71
739.78
669.70
669.49
502.02
499.63
Jun-21
C
1960.64
1996.61
888.02
814.76
814.48
557.11
558.84
Sep-21
C
1967.86
2006.62
837.18
759.83
759.62
606.46
606.60
Dec-21
C
2493.24
2509.86
1113.80
1033.89
1033.66
902.24
902.87
Mar-22
C
2518.44
2570.83
1156.81
1075.82
1075.74
894.64
894.02
Jun-22
C
2254.52
2342.91
935.09
851.43
851.30
702.01
705.58
Sep-22
C
1854.54
1934.62
701.12
615.39
615.22
493.60
496.02
* C - Consolidated, S - Standalone